参考文献/References:
[1] OLSSON T,BARCELLOS L F,ALFREDSSON L.Interactions between genetic,lifestyle and environmental risk factors for multiple sclerosis[J].Nat Rev Neurol,2017,13(1):25-36.
[2] HEDSTRM A K,BOMFIM I L,BARCELLOS L,et al.Interaction between adolescent obesity and HLA risk genes in the etiology of multiple sclerosis[J].Neurology,2014,82(10):865-872.
[3] THOMPSON A J,BANWELL B L,BARKHOF F,et al.Diagnosis of multiple sclerosis:2017 revisions of the McDonald criteria[J].Lancet Neurol,2018,17(2):162-173.
[4] PARNELL G P,BOOTH D R.The multiple sclerosis (MS) genetic risk factors indicate both acquired and innate immune cell subsets contribute to MS pathogenesis and identify novel therapeutic opportunities[J].Front Immunol,2017,8(2):420-425.
[5] 朱红敏,刘智胜.2017年多发性硬化McDonald诊断标准修订版解读[J].中华实用儿科临床杂志,2018,33(12):895-899.
ZHU H M,LIU Z S.An interpretation of diagnosis of multiple sclerosis (2007 revisions of the McDonald criteria)[J].Chin J Appl Clin Pediatr,2018,33(12):895-899.
[6] HEDSTRM A K,OLSSON T,ALFREDSSON L.High body mass index before age 20 is associated with increased risk for multiple sclerosis in both men and women[J].Mult Scler,2012,18(9):1334-1336.
[7] MUNGER K L,BENTZEN J,LAURSEN B,et al.Childhood body mass index and multiple sclerosis risk:a long-term cohort study[J].Mult Scler,2013,19(10):1323-1329.
[8] WESNES K,MYHR K M,RIISE T,et al.Physical activity is associated with a decreased multiple sclerosis risk:the EnvIMS study[J].Mult Scler,2018,24(2):150-157.
[9] ABDOLLAHPOUR I,NEDJAT S,MANSOURNIA M A,et al.Lifestyle factors and multiple sclerosis:a population-based incident case-control study[J].Mult Scler Relat Disord,2018,22:128-133.
[10] 张晓春,王晓明.多发性硬化中脑铁沉积的病理、临床及MRI研究新进展[J].中国医学影像技术,2010,26(11):2205-2208.
ZHANG X C,WANG X M.Progress of pathological,clinical and MRI study on iron deposition in the brain of the multiple sclerosis[J].Chin J Med Imaging Technol,2010,26(11):2205-2208.
[11] 朴松兰,杨小存,马长春.多发性硬化免疫相关病因和发病机制的研究进展[J].中国老年学杂志,2020,40(13):2900-2904.
PU S L,YANG X C,MA C C.Research progress on immune related etiology and pathogenesis of multiple sclerosis[J].Chin J Gerontol,2020,40(13):2900-2904.
[12] IFERGAN I,WOSIK K,CAYROL R,et al.Statins reduce human blood-brain barrier permeability and restrict leukocyte migration:relevance to multiple sclerosis[J].Ann Neurol,2006,60(1):45-55.
[13] 徐艳芳,张金文.多发性硬化的干细胞治疗进展[J].实用医药杂志,2020,37(6):562-566.
XU Y F,ZHANG J W.Advances in multiple sclerosis stem cell therapy[J].Pract J Med Pharm,2020,37(6):562-566.
[14] MURARO P A,PASQUINI M,ATKINS H L,et al.Long-term outcomes after autologous hematopoietic stem cell transplantation for multiple sclerosis[J].JAMA Neurol,2017,74(4):459-469.
[15] 李丹,王黙,纪元,等.Th17/Treg细胞及相关炎性因子在复发缓解型多发性硬化中的作用及机制[J].中国神经免疫学和神经病学杂志,2019,26(2):89-93,98.
LI D,WANG M,JI Y,et al.Role of Th17/Treg cells and related cytokines in patients with relapsing remitting multiple sclerosis[J].Chin J Neuroimmunol Neurol,2019,26(2):89-93,98.